Literature DB >> 10409649

Fyn and JAK2 mediate Ras activation by reactive oxygen species.

J Abe1, B C Berk.   

Abstract

Reactive oxygen species (ROS) activate Ras and the extracellular signal-regulated kinase (ERK) cascade. Because JAK2 is a critical mediator for Ras/Raf/ERK activation by several hormones, we examined the role of JAK2 in ROS signal events. H(2)O(2) stimulated JAK2 activity in fibroblasts with peak at 2-5 min. To determine the specific role of Src and Fyn as mediators of JAK2 activation and its downstream events, we used fibroblasts derived from transgenic mice deficient in Src (Src-/-) or Fyn (Fyn-/-). H(2)O(2)-stimulated JAK2 activity was completely inhibited in Fyn-/- cells. Shc tyrosine phosphorylation and Ras activation by H(2)O(2) were also significantly reduced in Fyn-/- cells, but not altered in Src-/- cells. Activation of JAK2 was restored when Fyn-/- cells were transfected with B-Fyn but not with Src. Inhibiting JAK2 activity with the specific inhibitor AG-490 prevented H(2)O(2) stimulated Shc and Ras activation. H(2)O(2)-mediated ERK1/2 activation in Fyn-/- cells and AG-490 treated cells was completely inhibited at an early time (5 min), but not at late times (20-40 min) after stimulation. These results define a new redox-sensitive pathway for Ras activation and rapid ERK1/2 activation, which is mediated by Fyn and JAK2.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10409649     DOI: 10.1074/jbc.274.30.21003

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  SOXF: redox mediators of vascular smooth muscle cell growth.

Authors:  Z G Jin; B C Berk
Journal:  Heart       Date:  2004-05       Impact factor: 5.994

2.  Cyanidin-3-glucoside suppresses TNF-α-induced cell proliferation through the repression of Nox activator 1 in mouse vascular smooth muscle cells: involvement of the STAT3 signaling.

Authors:  Xiaoqin Luo; Shi Fang; Yunjun Xiao; Fenglin Song; Tangbin Zou; Min Wang; Min Xia; Wenhua Ling
Journal:  Mol Cell Biochem       Date:  2011-11-26       Impact factor: 3.396

3.  Tyrosine phosphorylation controls nuclear export of Fyn, allowing Nrf2 activation of cytoprotective gene expression.

Authors:  James W Kaspar; Anil K Jaiswal
Journal:  FASEB J       Date:  2010-11-19       Impact factor: 5.191

4.  Methylmercury augments Nrf2 activity by downregulation of the Src family kinase Fyn.

Authors:  Megan Culbreth; Ziyan Zhang; Michael Aschner
Journal:  Neurotoxicology       Date:  2017-07-20       Impact factor: 4.294

5.  Subtype-specific translocation of the delta subtype of protein kinase C and its activation by tyrosine phosphorylation induced by ceramide in HeLa cells.

Authors:  T Kajimoto; S Ohmori; Y Shirai; N Sakai; N Saito
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

6.  Transforming growth factor-β downregulates sGC subunit expression in pulmonary artery smooth muscle cells via MEK and ERK signaling.

Authors:  Lili Du; Jesse D Roberts
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-09-27       Impact factor: 5.464

7.  NADPH oxidase and extracellular regulated kinases 1/2 are targets of prion protein signaling in neuronal and nonneuronal cells.

Authors:  Benoît Schneider; Vincent Mutel; Mathéa Pietri; Myriam Ermonval; Sophie Mouillet-Richard; Odile Kellermann
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-03       Impact factor: 11.205

8.  Leukocyte antigen-related protein tyrosine phosphatase negatively regulates hydrogen peroxide-induced vascular smooth muscle cell apoptosis.

Authors:  Juxiang Li; Xi-Lin Niu; Nageswara R Madamanchi
Journal:  J Biol Chem       Date:  2008-10-14       Impact factor: 5.157

Review 9.  JAK redux: a second look at the regulation and role of JAKs in the heart.

Authors:  Mazen Kurdi; George W Booz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-08-28       Impact factor: 4.733

10.  Study of total antioxidant status and glutathione peroxidase activity in Tunisian vitiligo patients.

Authors:  Akrem Jalel; Mohamed Hédi Hamdaoui
Journal:  Indian J Dermatol       Date:  2009       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.